Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma.

Featherall J, Curtis GL, Lawrenz JM, Jin Y, George J, Scott J, Shah C, Shepard D, Rubin BP, Nystrom LM, Mesko NW.

J Surg Oncol. 2019 Oct 6. doi: 10.1002/jso.25719. [Epub ahead of print]

PMID:
31587292
2.

PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid.

Marchiò C, Da Cruz Paula A, Gularte-Merida R, Basili T, Brandes A, da Silva EM, Silveira C, Ferrando L, Metovic J, Maletta F, Annaratone L, Pareja F, Rubin BP, Hoschar AP, De Rosa G, La Rosa S, Bongiovanni M, Purgina B, Piana S, Volante M, Weigelt B, Reis-Filho JS, Papotti M.

Mod Pathol. 2019 Jul 4. doi: 10.1038/s41379-019-0313-x. [Epub ahead of print]

PMID:
31273314
3.

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.

Serrano C, Mariño-Enríquez A, Tao DL, Ketzer J, Eilers G, Zhu M, Yu C, Mannan AM, Rubin BP, Demetri GD, Raut CP, Presnell A, McKinley A, Heinrich MC, Czaplinski JT, Sicinska E, Bauer S, George S, Fletcher JA.

Br J Cancer. 2019 Jul;121(3):281. doi: 10.1038/s41416-019-0487-5.

4.

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.

Serrano C, Mariño-Enríquez A, Tao DL, Ketzer J, Eilers G, Zhu M, Yu C, Mannan AM, Rubin BP, Demetri GD, Raut CP, Presnell A, McKinley A, Heinrich MC, Czaplinski JT, Sicinska E, Bauer S, George S, Fletcher JA.

Br J Cancer. 2019 Mar;120(6):612-620. doi: 10.1038/s41416-019-0389-6. Epub 2019 Feb 22. Erratum in: Br J Cancer. 2019 May 23;:.

PMID:
30792533
5.

The Molecular Diagnostics of Vascular Neoplasms.

Habeeb O, Rubin BP.

Surg Pathol Clin. 2019 Mar;12(1):35-49. doi: 10.1016/j.path.2018.10.002. Epub 2018 Dec 4. Review.

PMID:
30709447
6.

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas.

Pareja F, Geyer FC, Brown DN, Sebastião APM, Gularte-Mérida R, Li A, Edelweiss M, Da Cruz Paula A, Selenica P, Wen HY, Jungbluth AA, Varga Z, Palazzo J, Rubin BP, Ellis IO, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2019 Jan 18;5:6. doi: 10.1038/s41523-018-0101-7. eCollection 2019.

7.

A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical Veins.

Kobayashi H, Kobayashi Y, Yuasa S, Okabe M, Yamada Y, Oda Y, Debiec-Rychter M, Rubin BP, Suzuki T.

Am J Case Rep. 2018 Dec 19;19:1507-1514. doi: 10.12659/AJCR.911659.

8.

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.

Lowery CD, Dowless M, Renschler M, Blosser W, VanWye AB, Stephens JR, Iversen PW, Lin AB, Beckmann RP, Krytska K, Cole KA, Maris JM, Hawkins DS, Rubin BP, Kurmasheva RT, Houghton PJ, Gorlick R, Kolb EA, Kang MH, Reynolds CP, Erickson SW, Teicher BA, Smith MA, Stancato LF.

Clin Cancer Res. 2019 Apr 1;25(7):2278-2289. doi: 10.1158/1078-0432.CCR-18-2728. Epub 2018 Dec 18.

PMID:
30563935
9.

Desmoplastic Small Round Cell Tumors With Atypical Presentations: A Report of 34 Cases.

Al-Ibraheemi A, Broehm C, Tanas MR, Horvai AE, Rubin BP, Cheah AL, Thway K, Fisher C, Bahrami A, Folpe AL, Fritchie KJ.

Int J Surg Pathol. 2019 May;27(3):236-243. doi: 10.1177/1066896918817140. Epub 2018 Dec 6.

PMID:
30522375
10.

Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database.

Lawrenz JM, Curtis GL, Styron JF, George J, Anderson PM, Zahler S, Shepard DR, Rubin BP, Nystrom LM, Mesko NW.

Sarcoma. 2018 Nov 11;2018:1728302. doi: 10.1155/2018/1728302. eCollection 2018.

11.

Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.

Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Berry R, Rubin BP, Nafa K, Wang L, Klimstra DS, Ladanyi M, Hameed MR.

Mod Pathol. 2019 May;32(5):609-620. doi: 10.1038/s41379-018-0175-7. Epub 2018 Nov 21.

12.

Genetic and molecular reappraisal of spindle cell adamantinoma of bone reveals a small subset of misclassified intraosseous synovial sarcoma.

Horvai A, Dashti NK, Rubin BP, Kilpatrick SE, Rudzinski ER, Lopez-Terrada D, Hubley MB, Davis JL, Fritchie K.

Mod Pathol. 2019 Feb;32(2):231-241. doi: 10.1038/s41379-018-0115-6. Epub 2018 Sep 11.

PMID:
30206413
13.

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, Da Cruz Paula A, Kumar R, Brown DN, Gularte-Mérida R, Alemar B, Bi R, Lim RS, de Bruijn I, Fujisawa S, Gardner R, Feng E, Li A, da Silva EM, Lozada JR, Blecua P, Cohen-Gould L, Jungbluth AA, Rakha EA, Ellis IO, Edelweiss MIA, Palazzo J, Norton L, Hollmann T, Edelweiss M, Rubin BP, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 Aug 30;9(1):3533. doi: 10.1038/s41467-018-05886-y.

14.

EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.

Michal M, Berry RS, Rubin BP, Kilpatrick SE, Agaimy A, Kazakov DV, Steiner P, Ptakova N, Martinek P, Hadravsky L, Michalova K, Szep Z, Michal M.

Am J Surg Pathol. 2018 Oct;42(10):1325-1333. doi: 10.1097/PAS.0000000000001109.

PMID:
29957732
15.

Quantification of fat content in lipid-rich myxoid liposarcomas with MRI: a single-center experience with survival analysis.

Kuyumcu G, Rubin BP, Bullen J, Ilaslan H.

Skeletal Radiol. 2018 Oct;47(10):1411-1417. doi: 10.1007/s00256-018-2974-9. Epub 2018 Jun 8.

PMID:
29948035
16.

ALK Expression in Angiomatoid Fibrous Histiocytoma: A Potential Diagnostic Pitfall.

Cheah AL, Zou Y, Lanigan C, Billings SD, Rubin BP, Hornick JL, Goldblum JR.

Am J Surg Pathol. 2019 Jan;43(1):93-101. doi: 10.1097/PAS.0000000000001103.

PMID:
29877921
17.

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R, Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada JR, Blecua P, Muenst S, Jungbluth AA, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha EA, Chandarlapaty S, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 May 8;9(1):1816. doi: 10.1038/s41467-018-04128-5.

18.

Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.

Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, Dhillon G, Chee DR, Myers JT, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin BP, Huang AY, Meltzer PS, Helman LJ, Picci P, Versteeg HH, Stamatoyannopoulos JA, Khanna C, Scacheri PC.

Nat Med. 2018 Apr 10;24(4):525. doi: 10.1038/nm0418-525c.

PMID:
29634688
19.

Superficial Solitary Fibrous Tumor: A Series of 26 Cases.

Feasel P, Al-Ibraheemi A, Fritchie K, Zreik RT, Wang WL, Demicco E, Saeb-Lima M, Goldblum JR, Rubin BP, McKenney JK, Ko JS, Billings SD.

Am J Surg Pathol. 2018 Jun;42(6):778-785. doi: 10.1097/PAS.0000000000001027.

PMID:
29438169
20.

Positively selected enhancer elements endow osteosarcoma cells with metastatic competence.

Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, Dhillon G, Chee DR, Myers JT, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin BP, Huang AY, Meltzer PS, Helman LJ, Picci P, Versteeg HH, Stamatoyannopoulos JA, Khanna C, Scacheri PC.

Nat Med. 2018 Feb;24(2):176-185. doi: 10.1038/nm.4475. Epub 2018 Jan 15. Erratum in: Nat Med. 2018 Apr 10;24(4):525.

21.

Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α.

Lowery CD, Blosser W, Dowless M, Knoche S, Stephens J, Li H, Surguladze D, Loizos N, Luffer-Atlas D, Oakley GJ 3rd, Guo Q, Iyer S, Rubin BP, Stancato L.

Clin Cancer Res. 2018 Feb 15;24(4):847-857. doi: 10.1158/1078-0432.CCR-17-1258. Epub 2017 Nov 30.

22.

Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.

Perry KD, Al-Lbraheemi A, Rubin BP, Jen J, Ren H, Jang JS, Nair A, Davila J, Pambuccian S, Horvai A, Sukov W, Tazelaar HD, Folpe AL.

Mod Pathol. 2017 Oct;30(10):1512. doi: 10.1038/modpathol.2017.116.

23.

Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).

Mukhopadhyay S, Feldman MD, Abels E, Ashfaq R, Beltaifa S, Cacciabeve NG, Cathro HP, Cheng L, Cooper K, Dickey GE, Gill RM, Heaton RP Jr, Kerstens R, Lindberg GM, Malhotra RK, Mandell JW, Manlucu ED, Mills AM, Mills SE, Moskaluk CA, Nelis M, Patil DT, Przybycin CG, Reynolds JP, Rubin BP, Saboorian MH, Salicru M, Samols MA, Sturgis CD, Turner KO, Wick MR, Yoon JY, Zhao P, Taylor CR.

Am J Surg Pathol. 2018 Jan;42(1):39-52. doi: 10.1097/PAS.0000000000000948.

24.

NFκB signaling in alveolar rhabdomyosarcoma.

Cleary MM, Mansoor A, Settelmeyer T, Ijiri Y, Ladner KJ, Svalina MN, Rubin BP, Guttridge DC, Keller C.

Dis Model Mech. 2017 Sep 1;10(9):1109-1115. doi: 10.1242/dmm.030882.

25.

Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.

Perry KD, Al-Lbraheemi A, Rubin BP, Jen J, Ren H, Jang JS, Nair A, Davila J, Pambuccian S, Horvai A, Sukov W, Tazelaar HD, Folpe AL.

Mod Pathol. 2017 Nov;30(11):1589-1602. doi: 10.1038/modpathol.2017.83. Epub 2017 Jul 21. Erratum in: Mod Pathol. 2017 Oct;30(10 ):1512.

26.

Imaging features of mammary-type myofibroblastoma of soft tissue: a case series with literature review.

Kuyumcu G, Rubin BP, Winalski C.

Skeletal Radiol. 2017 Sep;46(9):1283-1291. doi: 10.1007/s00256-017-2678-6. Epub 2017 Jun 1. Review.

PMID:
28573464
27.

Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.

Hayashi Y, Toyomasu Y, Saravanaperumal SA, Bardsley MR, Smestad JA, Lorincz A, Eisenman ST, Cipriani G, Nelson Holte MH, Al Khazal FJ, Syed SA, Gajdos GB, Choi KM, Stoltz GJ, Miller KE, Kendrick ML, Rubin BP, Gibbons SJ, Bharucha AE, Linden DR, Maher LJ 3rd, Farrugia G, Ordog T.

Gastroenterology. 2017 Aug;153(2):521-535.e20. doi: 10.1053/j.gastro.2017.04.020. Epub 2017 Apr 21.

28.

Erratum to: MicroCT-Based Virtual Histology Evaluation of Preclinical Medulloblastoma.

Prajapati SI, Kilcoyne A, Samano AK, Green DP, McCarthy SD, Blackman BA, Brady MM, Zarzabal LA, Tatiparthi AK, Sledz TJ, Duong T, Ohshima-Hosoyama S, Giles FJ, Michalek JE, Rubin BP, Keller C.

Mol Imaging Biol. 2017 Jun;19(3):483. doi: 10.1007/s11307-017-1079-5. No abstract available.

PMID:
28389781
29.

Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.

Geyer FC, Burke KA, Piscuoglio S, Ng CKY, Papanastasiou AD, Marchiò C, Selenica P, Edelweiss M, Murray MP, Brogi E, Soslow RA, Rubin BP, Norton L, Reis-Filho JS, Weigelt B.

Mol Oncol. 2017 Aug;11(8):913-926. doi: 10.1002/1878-0261.12049. Epub 2017 May 16.

30.

Broadening the Anatomic Landscape of Sclerosing Perineurioma: A Series of 5 Cases in Nonacral Sites.

Erstine EM, Ko JS, Rubin BP, McKenney JK, Goldblum JR, Billings SD.

Am J Dermatopathol. 2017 Sep;39(9):679-681. doi: 10.1097/DAD.0000000000000773.

PMID:
27845943
31.

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.

Bean GR, Kremer JC, Prudner BC, Schenone AD, Yao JC, Schultze MB, Chen DY, Tanas MR, Adkins DR, Bomalaski J, Rubin BP, Michel LS, Van Tine BA.

Cell Death Dis. 2016 Oct 13;7(10):e2406. doi: 10.1038/cddis.2016.232.

32.

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Cleven AH, Al Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV.

Mod Pathol. 2016 Sep;29(9):1113. doi: 10.1038/modpathol.2016.103. No abstract available.

33.

Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery.

Kang H, Gravier J, Bao K, Wada H, Lee JH, Baek Y, El Fakhri G, Gioux S, Rubin BP, Coll JL, Choi HS.

Adv Mater. 2016 Oct;28(37):8162-8168. doi: 10.1002/adma.201601101. Epub 2016 Jul 14.

34.

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.

Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Settelmeyer TP, Young MC, Peckham JL, Cho YJ, Michalek JE, Hernandez BS, Berlow NE, Jackson M, Guillaume DJ, Selden NR, Bigner DD, Nazemi KJ, Green SC, Corless CL, Gultekin S, Mansoor A, Rubin BP, Woltjer R, Keller C.

Sci Rep. 2016 Jun 3;6:27012. doi: 10.1038/srep27012.

35.

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.

Fang D, Gan H, Lee JH, Han J, Wang Z, Riester SM, Jin L, Chen J, Zhou H, Wang J, Zhang H, Yang N, Bradley EW, Ho TH, Rubin BP, Bridge JA, Thibodeau SN, Ordog T, Chen Y, van Wijnen AJ, Oliveira AM, Xu RM, Westendorf JJ, Zhang Z.

Science. 2016 Jun 10;352(6291):1344-8. doi: 10.1126/science.aae0065. Epub 2016 May 26.

36.

Follicular Dendritic Cell Sarcoma of Appendix Presenting as Acute Appendicitis: An Exceptionally Rare Case Report.

Ahmed A, Ud Din N, Alvi AR, Rubin BP.

Int J Surg Pathol. 2016 Oct;24(7):631-4. doi: 10.1177/1066896916651494. Epub 2016 May 25.

PMID:
27225654
37.

Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases.

Lo RC, Suriawinata AA, Rubin BP.

Clin Mol Hepatol. 2016 Mar;22(1):188-91. doi: 10.3350/cmh.2016.22.1.188.

38.

Angiosarcoma arising in association with vascular Dacron grafts and orthopedic joint prostheses: clinicopathologic, immunohistochemical, and molecular study.

Agaimy A, Ben-Izhak O, Lorey T, Scharpf M, Rubin BP.

Ann Diagn Pathol. 2016 Apr;21:21-8. doi: 10.1016/j.anndiagpath.2016.01.002. Epub 2016 Jan 11. Review.

PMID:
27040926
39.

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV.

Mod Pathol. 2016 Jun;29(6):582-90. doi: 10.1038/modpathol.2016.45. Epub 2016 Mar 18. Erratum in: Mod Pathol. 2016 Sep;29(9):1113.

40.

NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.

Fritchie KJ, Jin L, Rubin BP, Burger PC, Jenkins SM, Barthelmeß S, Moskalev EA, Haller F, Oliveira AM, Giannini C.

J Neuropathol Exp Neurol. 2016 Mar;75(3):263-71. doi: 10.1093/jnen/nlv026. Epub 2016 Feb 16.

PMID:
26883114
41.

Uterine adenosarcomas are mesenchymal neoplasms.

Piscuoglio S, Burke KA, Ng CK, Papanastasiou AD, Geyer FC, Macedo GS, Martelotto LG, de Bruijn I, De Filippo MR, Schultheis AM, Ioris RA, Levine DA, Soslow RA, Rubin BP, Reis-Filho JS, Weigelt B.

J Pathol. 2016 Feb;238(3):381-8. doi: 10.1002/path.4675. Epub 2015 Dec 28.

42.

Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.

Patil DT, Ma S, Konishi M, Carver PD, Pukay M, Beadling C, Corless CL, Rubin BP.

Am J Clin Pathol. 2015 Nov;144(5):782-9. doi: 10.1309/AJCPRK3V2EIIUPQZ.

PMID:
26486743
43.

Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.

Piscuoglio S, Fusco N, Ng CK, Martelotto LG, da Cruz Paula A, Katabi N, Rubin BP, Skálová A, Weinreb I, Weigelt B, Reis-Filho JS.

Histopathology. 2016 Jun;68(7):1055-62. doi: 10.1111/his.12883. Epub 2016 Jan 4.

44.

Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.

Verschoor AJ, Cleton-Jansen AM, Wijers-Koster P, Coffin CM, Lazar AJ, Nout RA, Rubin BP, Gelderblom H, Bovée JV.

Am J Surg Pathol. 2015 Dec;39(12):1701-7. doi: 10.1097/PAS.0000000000000510.

PMID:
26414222
45.

Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?

Patil DT, Rubin BP.

Surg Pathol Clin. 2015 Sep;8(3):515-24. doi: 10.1016/j.path.2015.05.006. Epub 2015 Jul 7. Review.

PMID:
26297068
46.

Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.

Tanas MR, Ma S, Jadaan FO, Ng CK, Weigelt B, Reis-Filho JS, Rubin BP.

Oncogene. 2016 Feb 18;35(7):929-38. doi: 10.1038/onc.2015.148. Epub 2015 May 11.

47.

Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors.

Atanaskova Mesinkovska N, Buehler D, McClain CM, Rubin BP, Goldblum JR, Billings SD.

J Cutan Pathol. 2015 Sep;42(9):622-31. doi: 10.1111/cup.12514. Epub 2015 Jun 11.

PMID:
25950586
48.

Incidental imaging finding of chest wall mass.

Patel RN, Kiczek MP, Rubin BP, Winalski CS.

Skeletal Radiol. 2015 Sep;44(9):1357, 1393-4. doi: 10.1007/s00256-015-2147-z. No abstract available.

PMID:
25935459
49.

Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.

Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo KM, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T.

Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.

50.

Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.

Patel NR, Salim AA, Sayeed H, Sarabia SF, Hollingsworth F, Warren M, Jakacky J, Tanas M, Oliveira AM, Rubin BP, Lazar AJ, López-Terrada D, Wang WL.

Histopathology. 2015 Nov;67(5):699-708. doi: 10.1111/his.12697. Epub 2015 May 14.

PMID:
25817592

Supplemental Content

Loading ...
Support Center